Tech Company Financing Transactions
Tissue Regeneration Systems Funding Round
Tissue Regeneration Systems, based in Plymouth, received $3.6 million from private investors.
Transaction Overview
Company Name
Announced On
8/16/2013
Transaction Type
Venture Equity
Amount
$3,638,821
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation. The offering is completed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
46701 Commerce Center Dr.
Plymouth, MI 48170
USA
Plymouth, MI 48170
USA
Phone
Website
Email Address
Not Recorded
Overview
Tissue Regeneration Systems (TRS) is a start-up medical device company commercializing a breakthrough skeletal reconstruction and bone regeneration technology platform licensed from the Universities of Michigan and Wisconsin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
James Adox
Chief Executive Officer
James Fitzsimmons
VP - Bus. Development
Sharon Schulzki
Browse more venture capital transactions:
Prev: 8/16/2013: Acutus Medical venture capital transaction
Next: 8/16/2013: Inovus Solar venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs